THE CRITICAL PATH INSTITUTE (C-PATH) NON PROFIT CORPORATION -  

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 2.281.840 0 1
2019 0 13.999.998 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
PFIZER LIMITED2
ABBVIE INC1
ABX CRO ADVANCED PHARMACEUTICAL SERVICES FORSCHUNGSGESELLSCHAFT MBH1
ADELPHI VALUES1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
BAYER1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONSORCIO MAR PARC DE SALUT DE BARCELONA1
ELI LILLY AND COMPANY LIMITED1
ESD EVALUATION SOFTWARE DEVELOPMENT1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY1
F HOFFMANNLA ROCHE1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
FUNDACION PUBLICA MIGUEL SERVET1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
JANSSEN PHARMACEUTICA NV1
JOHNS HOPKINS UNIVERSITY1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KLINICKI BOLNICKI CENTAR RIJEKA1
LANDSPITALI UNIVERSITY HOSPITAL1
LEIDEN UNIVERSITY1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
METAHEPS1
MLM MEDICAL LABS1
MODUS OUTCOMES SAS1
MYELOMA PATIENTS EUROPE AISBL1
NATIONAL CANCER CENTER1
NOVARTIS PHARMA1
OSLO UNIVERSITETSSYKEHUS HF1
QUEEN'S UNIVERSITY AT KINGSTON1
REGION HOVEDSTADEN1
SANOFIAVENTIS1
SERVICIO ANDALUZ DE SALUD1
SIGNATOPE1
STATENS LEGEMIDDELVERK1
STICHTING VUMC1
STIFTUNG FUR QUALITAT UND WIRTSCHAFTLICHKEIT IM GESUNDHEITSWESEN1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TAMIRNA1
THE EUROPEAN MEDICINES AGENCY1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF NOTTINGHAM1
THE UNIVERSITY OF SYDNEY1
UNIVERSIDAD DE MALAGA1
UNIVERSIDAD DE SALAMANCA1
UNIVERSITAET BERN1
UNIVERSITAET ZUERICH1
UNIVERSITAETSKLINIKUM FREIBURG1
UNIVERSITEIT GENT1
UNIVERSITY HEALTH NETWORK1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF LEEDS1
UNIVERSITY OF NEWCASTLE UPON TYNE1

Constancy:

Total number of partners: 60
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 60
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99829